Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a drug
delivery platform innovator, this morning announced strategic additions to its
patent portfolio. Per the update, three new Australian patents were recently
granted to Lexaria by the Australian Patent Office, bringing the company’s
total number of issued patents to eight, including four in the U.S. and four in
Australia. All eight patents are within Lexaria’s first patent family, “Food
and Beverage Compositions Infused With Lipophilic Active Agents and Methods of
Use Thereof.” Additionally, the company received two new Notices of Allowance
from the U.S. Patent & Trademark Office for pending patent applications,
and it expects to receive the corresponding U.S. patents prior to year-end
2018. To date, Lexaria has filed over 50 patent applications across nine patent
families. With this large collection of filings and at least seven more patent
families planned, Lexaria intends to disclose material patent filings and
issuances moving forward, but not each patent-related development.
To view the full press release, visit http://ibn.fm/l93hM
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. licenses disruptive patented
delivery technology that promotes healthier ingestion methods, lower overall
dosing and higher effectiveness of lipophilic active molecules. Lexaria has
multiple patents pending in over 40 countries around the world and has patents
granted in the USA and in Australia for utilization of its DehydraTECH™
delivery technology. Lexaria’s technology provides increases in intestinal
absorption rates; more rapid delivery to the bloodstream; and important
taste-masking benefits, for orally administered bioactive molecules including
cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),
nicotine and other molecules. For more information, visit the company’s website
at www.LexariaBioscience.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment